EUVIMEDEUVIMED entdecken
Multizentrische StudieMetaanalyseOpen Access · CC BY 4.0

Urinary Acetaminophen Metabolites and Clinical Outcomes in Extremely Premature Infants

Miguel Guardado, Dara Torgerson, Cheryl Chapin, Azuka Atum, Ryan D Hernandez, Ronald Clyman, Rebecca Simmons, Samuel Parry, Philip L Ballard

American Journal of Perinatology · 01.09.2025 · 42 (12) · 1576-1587

DOI: 10.1055/a-2512-9387 ↗

Kurz gefasst

Multizentrische Studie in der Zeitschrift American Journal of Perinatology, erschienen am 01.09.2025. Verfasst von Miguel Guardado und 8 weiteren Autor:innen. Beteiligte Einrichtung: Department of Biological and Medical Informatics, University of California, San Francisco, San Francisco, California. Hauptthemen laut MEDLINE: Infant, Extremely Premature, Acetaminophen, Bronchopulmonary Dysplasia, Retinopathy of Prematurity. Die Arbeit nennt 41 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: NIGMS NIH HHS, NHLBI NIH HHS, NIH grants.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Extremely premature infants are treated with acetaminophen (APAP) for pain and patent ductus arteriosus. High doses of APAP in adults are toxic, and a recent study found an association between APAP metabolite levels in mothers' breast milk and both bronchopulmonary dysplasia (BPD) and retinopathy of prematurity (ROP) in their premature infants. In this study, we determined levels of APAP metabolites in the urine of infants at high risk for BPD and ROP. Biorepository urine samples from 314 infants

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Infant, Extremely PrematureAcetaminophenBronchopulmonary DysplasiaRetinopathy of PrematurityAnalgesics, Non-NarcoticHumansInfant, NewbornFemaleMaleLogistic ModelsDuctus Arteriosus, PatentMultivariate AnalysisTandem Mass SpectrometryGestational Age

Substanzen

AcetaminophenAnalgesics, Non-Narcotic

Autor:innen und Institutionen

  • Department of Biological and Medical Informatics, University of California, San Francisco, San Francisco, California.
  • Department of Epidemiology and Biostatistics, University of California, San Francisco, San Francisco, California.
  • Department of Pediatrics, University of California, San Francisco, San Francisco, California.
  • Department of Bioengineering and Therapeutic Sciences, University of California San Francisco, San Francisco, California.
  • Department of Pediatrics, Perelman School of Medicine, University of Pennsylvania, Children's Hospital of Philadelphia, Philadelphia, Pennsylvania.
  • Department of Obstetrics and Gynecology, Perelman School of Medicine, University of Pennsylvania, Philadelphia, Pennsylvania.

Förderung

  • NIGMS NIH HHS
  • NHLBI NIH HHS
  • NIH grants

Zitieren

APA

Guardado, M., Torgerson, D., Chapin, C., Atum, A., Hernandez, R. D., Clyman, R., Simmons, R., Parry, S., & Ballard, P. L. (2025). Urinary Acetaminophen Metabolites and Clinical Outcomes in Extremely Premature Infants. American Journal of Perinatology, 42(12), 1576-1587. https://doi.org/10.1055/a-2512-9387

Vancouver

Guardado M, Torgerson D, Chapin C, Atum A, Hernandez RD, Clyman R, et al. Urinary Acetaminophen Metabolites and Clinical Outcomes in Extremely Premature Infants. American Journal of Perinatology. 2025;42(12):1576-1587. doi:10.1055/a-2512-9387

BibTeX
@article{Guardado2025,
  author = {Guardado, Miguel and Torgerson, Dara and Chapin, Cheryl and Atum, Azuka and Hernandez, Ryan D and Clyman, Ronald and Simmons, Rebecca and Parry, Samuel and Ballard, Philip L},
  title = {Urinary Acetaminophen Metabolites and Clinical Outcomes in Extremely Premature Infants},
  journal = {American Journal of Perinatology},
  year = {2025},
  volume = {42},
  number = {12},
  pages = {1576--1587},
  doi = {10.1055/a-2512-9387}
}
Kostenlos starten →